171 filings
Page 2 of 9
6-K
n9ngzkftkp 7r1
9 May 23
MediWound Announces an Additional $10 Million Award from BARDA
7:35am
6-K
ub8gk1gbnayyrk 2z
20 Apr 23
Current report (foreign)
4:06pm
6-K
vlt19il4bu
16 Mar 23
MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and 2022 total revenues of $26.5 million
7:15am
6-K
7cw9ef
16 Mar 23
MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer
7:02am
6-K
uknp21ryqaf
13 Feb 23
Current report (foreign)
8:00am
6-K
7lhds w63z
7 Feb 23
Current report (foreign)
4:06pm
6-K
5exb9otgleoso
9 Jan 23
Current report (foreign)
6:09am
6-K
p4h67r
29 Dec 22
MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
1:52pm
6-K
uzw fdh0xwno9t
23 Dec 22
Current report (foreign)
8:10am
6-K
9njxpqv
20 Dec 22
Current report (foreign)
7:01am
6-K
4hg9ovkeob6phfffk
19 Dec 22
MediWound Announces Positive Results in U.S. Phase I/II Study of MW005
7:28am
6-K
6pq0qv79og39kbc
5 Dec 22
MediWound Announces a 1-for-7 Reverse Share Split
4:10pm
6-K
s40zn9xccy6 a8if
28 Nov 22
Current report (foreign)
4:05pm
6-K
q99ixnmr2bmbvwtu2rf
15 Nov 22
MediWound Reports Third Quarter 2022 Financial Results and Provides Company Update
7:05am
6-K
5jrt3tosci6n8u
9 Nov 22
Current report (foreign)
4:05pm
6-K
kytdpgt kjhjcuv
21 Oct 22
Current report (foreign)
4:05pm
6-K
u45mbgc5rqxe5ebn4b
26 Sep 22
MediWound Announces Concurrent Registered Direct
4:05pm
6-K
qjstmt3
20 Sep 22
Current report (foreign)
7:05am
6-K
xhs7ub6quzxht6hy15iq
9 Aug 22
MediWound Reports Second Quarter 2022 Financial Results and Provides
7:35am
6-K
jdbl27129ck0sgh8f
8 Aug 22
MediWound Enhances Its Board and Executive Leadership Team
4:10pm